https://www.selleckchem.com/
We also discuss its potential clinical application value as a diagnostic/prognostic biomarker for patients with malignant tumors.Gliomas are one of the most common types of primary brain tumors. Despite recent advances in the combination of surgery, radiotherapy, systemic therapy (chemotherapy, targeted therapy) and supportive therapy in the multimodal treatment of gliomas, the overall prognosis remains poor and the long‑term survival rate is low. Thus, it is crucial to develop a novel glioma management method. Due to its relatively non‑invasive, selective
Like
Comment
Share
